Senator questions penalty for vaccine data fraud; Japan readies for latest measles outbreak;

> Senator Chuck Grassley has questioned why the researcher who falsified AIDS vaccine data wasn't given a tougher penalty. News

> A jump in measles cases in Japan has raised fears the undervaccinated country faces another outbreak. Article

> Novartis ($NVS) is aiming to wrap up a strategic review of its underperforming vaccine unit by mid-year. Report

> John Hopkins researchers have developed an app to help hospitals forecast numbers of flu patients. Post

> Croatia's Institute of Immunology faces an uncertain future after losing key production licenses. Piece

> Research suggests vaccinating elder siblings against respiratory syncytial virus could stop babies from getting ill. Item

> Sinovac Biotech has applied to test its H7N9 vaccine in a clinical trial in China. Report

> iBio has begun a Phase I trial of its green plant-produced malaria vaccine. Release

> Sanofi-owned Shantha Biotechnics is developing polio vaccines. Article

> Canadian authorities have reassured the public about the effectiveness of the measles vaccine after three people fell ill despite being immunized. News

> The co-founder of Oracle ($ORCL) is to donate $100 million through his foundation to help eradicate polio. Item

> An outbreak of whooping cough has hit an Amish community in Delaware. Piece

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.